Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antineoplastics agents > Imatinib Mesylate 220127-57-1

Imatinib Mesylate 220127-57-1

Inquiry
  Post Date: May 07,2019
  Expiry Date: Nov 03,2019
  Detailed Description: Cas No. :220127-57-1 A tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL).

  CAS Registry Number:

220127-57-1

  Synonyms: ;Glivec;gleevec;imatinib methanesulfonate;imatinib mesilate;4-[(4-methylpiperazin-1-yl)methyl]-n-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate;4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate;Imatinibmesylate;Imatinib mesylate(Alpha form);
  Molecular Formula: C30H35N7O4S
  Molecular Weight: 589.71
  Molecular Structure: 220127-57-1 Imatinib Mesylate

  Company: Shanghai Neopharm Co., Ltd.     [ China ]          
  Contact: Carol Zhu
  Tel: 021-58826758
  Fax: 021-58827258
  Email: sales@neopharm.com.cn
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.